Krystal Biotech (FRA:4KB) Stock Based Compensation : €49.4 Mil (TTM As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Krystal Biotech Stock Based Compensation?

Krystal Biotech's Stock Based Compensation for the three months ended in Mar. 2025 was €12.5 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2025 was €49.4 Mil.

Krystal Biotech Stock Based Compensation Historical Data

The historical data trend for Krystal Biotech's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krystal Biotech Stock Based Compensation Chart

Krystal Biotech Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Stock Based Compensation

Get a 7-Day Free Trial

2.69

13.56

31.37

36.62

46.92

Krystal Biotech Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Stock Based Compensation	Get a 7-Day Free Trial															8.56	12.22	12.00	12.76	12.47

Krystal Biotech Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €49.4 Mil.

Krystal Biotech Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Krystal Biotech's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

Krystal Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Krystal Biotech Inc (FRA:4KB) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

KRYS:USA 4KB:Germany

Address

2100 Wharton Street, Suite 701, Pittsburgh, PA, USA, 15203

Website

https://www.krystalbio.com

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Krystal Biotech Headlines

No Headlines